In addition, TOX-, DNM3-, KLHL42-, PGM2L1-, and SESN3-positive cells from advanced-stage MF patients were significantly increased and had a stronger staining compared to the dermis of early-stage MF patients (Figs. 4G, S6A). This evidence concerns the gene SESN3 and mycosis fungoides.